Sign In
Buy MRK
$119.05
-1.73 (-1.43%)
At Close: Jun 12, 2026
Calla Lily Clinical Care and Merck Announce Strategic Collaboration to Advance Intravaginal Drug Delivery Platform
04:35am, Tuesday, 10'th Feb 2026
LONDON--(BUSINESS WIRE)--Calla Lily Clinical Care, a women's health-focused medical technology company, and Merck, a leading science and technology company, have entered a strategic collaboration to s
Merck: The Spike Doesn't Make It Overvalued
01:32pm, Monday, 09'th Feb 2026
Merck has surged more than 50% in six months, underpinned by a robust asset portfolio and strong shareholder return strategy. Keytruda, MRK's top-selling drug, faces a 2028 patent cliff, but ongoing i
Merck: A Buy For 2026, But The Clock Is Still Ticking
09:55am, Monday, 09'th Feb 2026
Merck is rated Buy after extending Keytruda's patent protection to late-2029, delaying the anticipated patent cliff, and unlocking significant near-term value. The extended exclusivity creates a one-t
Oppenheimer Asset Management Inc. Has $46.50 Million Holdings in Merck & Co., Inc. $MRK
08:44am, Monday, 09'th Feb 2026
Oppenheimer Asset Management Inc. lifted its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 6.3% in the undefined quarter, according to the company in its most recent filing with the Securities
Merck & Co., Inc. $MRK Shares Acquired by Smartleaf Asset Management LLC
08:44am, Monday, 09'th Feb 2026
Smartleaf Asset Management LLC boosted its position in Merck and Co., Inc. (NYSE: MRK) by 21.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commi
Merck & Co., Inc. (NYSE:MRK) SVP Sells $765,888.00 in Stock
07:20am, Monday, 09'th Feb 2026
Merck and Co., Inc. (NYSE: MRK - Get Free Report) SVP Dalton Smart III sold 6,400 shares of the stock in a transaction dated Wednesday, February 4th. The shares were sold at an average price of $119.6
Insider Selling: Merck & Co., Inc. (NYSE:MRK) EVP Sells $609,550.00 in Stock
07:20am, Monday, 09'th Feb 2026
Merck and Co., Inc. (NYSE: MRK - Get Free Report) EVP David Michael Williams sold 5,000 shares of the firm's stock in a transaction that occurred on Friday, February 6th. The stock was sold at an aver
OPTIMAS CAPITAL Ltd Makes New Investment in Merck & Co., Inc. $MRK
06:46am, Monday, 09'th Feb 2026
OPTIMAS CAPITAL Ltd purchased a new stake in shares of Merck and Co., Inc. (NYSE: MRK) in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange
Merck & Co., Inc. (NYSE:MRK) VP Sells $1,791,882.99 in Stock
05:02am, Monday, 09'th Feb 2026
Merck and Co., Inc. (NYSE: MRK - Get Free Report) VP Dean Li sold 15,087 shares of the company's stock in a transaction on Wednesday, February 4th. The stock was sold at an average price of $118.77, f
Insider Selling: Merck & Co., Inc. (NYSE:MRK) Insider Sells $1,828,050.00 in Stock
05:02am, Monday, 09'th Feb 2026
Merck and Co., Inc. (NYSE: MRK - Get Free Report) insider Johannes Jacobus Oosthuizen sold 15,000 shares of the business's stock in a transaction on Friday, February 6th. The shares were sold at an av
From Bargain To Balancing Act: Merck's Next Test Begins (Rating Downgrade)
10:28pm, Sunday, 08'th Feb 2026
Merck & Co. is no longer a deep-value patent cliff trade but a fairly valued defensive compounder. Future returns now depend on execution and pipeline delivery, not multiple expansion. Keytruda erosio
Merck: Pipeline Building Despite The Light FY26 Guide, Major Momentum
09:56pm, Sunday, 08'th Feb 2026
Merck delivered a strong Q4 double beat, with robust pipeline momentum and a healthy new launch cycle supporting a continued buy rating. MRK raised its price target to $130, reflecting normalized $10
3 Top Dow Jones Dividend Stocks to Buy for Passive Income in 2026
09:25am, Sunday, 08'th Feb 2026
A saturated wireless market may limit Verizon's net growth potential, but the telecom business is perfect for recurring dividend payments. Merck's been positioning for renewed revenue growth -- for in
Robert Davis Sells 47,434 Shares of Merck & Co., Inc. (NYSE:MRK) Stock
04:02am, Sunday, 08'th Feb 2026
Merck and Co., Inc. (NYSE: MRK - Get Free Report) CEO Robert Davis sold 47,434 shares of the stock in a transaction that occurred on Wednesday, February 4th. The stock was sold at an average price of
5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (February 2026)
08:20am, Saturday, 07'th Feb 2026
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filter
